NCT06624072View on ClinicalTrials.gov

A Study in Healthy People to Compare 2 Different Formulations of Nerandomilast Tablets When Taken With or Without Food

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 15, 2024

Primary Completion Date

November 22, 2024

Study Completion Date

November 30, 2024

Conditions
Healthy
Interventions
DRUG

Nerandomilast, Formulation 1

Reference treatment (R)

DRUG

Nerandomilast, Formulation 2

when taken without food: Test Treatment 1 (T1) when taken with food: Test Treatment 2 (T2)

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT06624072 - A Study in Healthy People to Compare 2 Different Formulations of Nerandomilast Tablets When Taken With or Without Food | Biotech Hunter | Biotech Hunter